Total Payments
$683.42
2024 Payments
$106.33
Companies
7
Transactions
28
Medicare Patients
5,234
Medicare Billing
$547,928

Payment Breakdown by Category

Food & Beverage$683.42 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $683.42 28 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $259.04 14 $0 (2024)
Davol Inc. $258.67 2 $0 (2023)
Janssen Pharmaceuticals, Inc $86.77 6 $0 (2022)
PORTOLA PHARMACEUTICALS, INC. $28.57 2 $0 (2019)
PFIZER INC. $24.02 2 $0 (2019)
AstraZeneca Pharmaceuticals LP $13.85 1 $0 (2021)
SI-BONE, INC. $12.50 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $106.33 6 ABBVIE INC. ($106.33)
2023 $381.72 9 Davol Inc. ($258.67)
2022 $73.60 4 Janssen Pharmaceuticals, Inc ($43.94)
2021 $54.26 4 Janssen Pharmaceuticals, Inc ($27.91)
2019 $40.41 3 PORTOLA PHARMACEUTICALS, INC. ($28.57)
2018 $27.10 2 Janssen Pharmaceuticals, Inc ($14.92)

All Payment Transactions

28 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/13/2024 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $18.84 General
Category: ANTI-INFECTIVE
10/11/2024 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $18.46 General
Category: ANTI-INFECTIVE
09/25/2024 ABBVIE INC. TEFLARO (Drug) Food and Beverage In-kind items and services $16.06 General
Category: ANTI-INFECTIVE
07/08/2024 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $17.82 General
Category: ANTI-INFECTIVE
05/07/2024 ABBVIE INC. TEFLARO (Drug), DALVANCE Food and Beverage In-kind items and services $17.50 General
Category: ANTI-INFECTIVE
04/03/2024 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $17.65 General
Category: ANTI-INFECTIVE
12/22/2023 Davol Inc. ARISTA AH FlexiTip (Device) Food and Beverage In-kind items and services $147.18 General
Category: Surgery
12/19/2023 AbbVie Inc. TEFLARO (Drug) Food and Beverage In-kind items and services $17.43 General
Category: ANTI-INFECTIVE
11/14/2023 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $17.62 General
Category: ANTI-INFECTIVE
09/26/2023 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $16.87 General
Category: ANTI-INFECTIVE
08/07/2023 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $18.50 General
Category: ANTI-INFECTIVE
05/31/2023 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $18.51 General
Category: ANTI-INFECTIVE
05/26/2023 Davol Inc. Food and Beverage In-kind items and services $111.49 General
05/24/2023 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $17.64 General
Category: ANTI-INFECTIVE
03/28/2023 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $16.48 General
Category: ANTI-INFECTIVE
08/30/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.75 General
Category: Cardiovascular & Metabolism
07/12/2022 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $29.66 General
Category: ANTI-INFECTIVE
05/19/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.36 General
Category: Cardiovascular & Metabolism
04/21/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.83 General
Category: Cardiovascular & Metabolism
11/03/2021 SI-BONE, INC. IFUSE IMPLANT (Device) Food and Beverage Cash or cash equivalent $12.50 General
Category: SACROILIAC JOINT DYSFUNCTION
10/20/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.98 General
Category: Cardiovascular & Metabolism
10/14/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.93 General
Category: Cardiovascular & Metabolism
10/12/2021 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $13.85 General
Category: Cardiovascular and Metabolism
12/06/2019 PORTOLA PHARMACEUTICALS, INC. ANDEXXA (Biological) Food and Beverage Cash or cash equivalent $13.57 General
Category: HEMATOLOGY/NEUROLOGY
09/20/2019 PORTOLA PHARMACEUTICALS, INC. ANDEXXA (Biological) Food and Beverage Cash or cash equivalent $15.00 General
Category: HEMATOLOGY/NEUROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 1,161 1,191 $1.3M $119,652
2022 8 1,302 1,354 $1.4M $140,353
2021 9 1,495 1,575 $1.6M $157,177
2020 8 1,276 1,346 $1.4M $130,746
Total Patients
5,234
Total Services
5,466
Medicare Billing
$547,928
Procedure Codes
33

All Medicare Procedures & Services

33 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 436 452 $785,124 $68,330 8.7%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 220 227 $264,682 $22,974 8.7%
99291 Critical care, first 30-74 minutes Facility 2023 119 119 $232,288 $22,307 9.6%
99292 Critical care, each additional 30 minutes Facility 2023 21 25 $24,400 $2,389 9.8%
99283 Emergency department visit with low level of medical decision making Facility 2023 23 24 $18,768 $1,461 7.8%
93042 Electrocardiogram (ecg) 1 to 3 leads with review by physician only Facility 2023 227 229 $21,297 $1,306 6.1%
71045 X-ray of chest, 1 view Facility 2023 95 95 $2,185 $705.94 32.3%
71046 X-ray of chest, 2 views Facility 2023 20 20 $580.00 $178.80 30.8%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 504 527 $915,399 $86,161 9.4%
99291 Critical care, first 30-74 minutes Facility 2022 137 138 $269,376 $30,330 11.3%
99284 Emergency department visit for problem of high severity Facility 2022 119 123 $143,418 $12,821 8.9%
99292 Critical care, each additional 30 minutes Facility 2022 37 46 $44,896 $5,125 11.4%
99283 Emergency department visit for problem of moderate severity Facility 2022 46 46 $35,972 $2,851 7.9%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2022 232 243 $23,328 $1,621 7.0%
93042 Electrocardiogram (ecg) 1 to 3 leads with review by physician only Facility 2022 131 135 $12,555 $774.35 6.2%
71045 X-ray of chest, 1 view Facility 2022 96 96 $2,208 $669.10 30.3%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 583 622 $1.1M $103,954 9.6%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 125 129 $251,808 $28,678 11.4%
99284 Emergency department visit, problem of high severity Facility 2021 128 133 $155,078 $14,218 9.2%
99292 Critical care delivery critically ill or injured patient Facility 2021 25 33 $31,232 $3,662 11.7%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2021 391 413 $39,648 $2,848 7.2%
99283 Emergency department visit, moderately severe problem Facility 2021 39 39 $30,498 $2,327 7.6%
71045 X-ray of chest, 1 view Facility 2021 138 140 $3,220 $993.14 30.8%
93042 Interpretation and report of electrical activity of heart using 1-3 leads Facility 2021 50 50 $4,650 $280.59 6.0%
74022 Complete x-ray study of abdomen with single x-ray of chest Facility 2021 16 16 $1,696 $216.80 12.8%

About Dr. Michael Chow, D.O

Dr. Michael Chow, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Trenton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1720286628.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Chow, D.O has received a total of $683.42 in payments from pharmaceutical and medical device companies, with $106.33 received in 2024. These payments were reported across 28 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($683.42).

As a Medicare-enrolled provider, Chow has provided services to 5,234 Medicare beneficiaries, totaling 5,466 services with total Medicare billing of $547,928. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.

Practice Information

Products in Payments

  • DALVANCE (Drug) $208.05
  • ARISTA AH FlexiTip (Device) $147.18
  • XARELTO (Drug) $86.77
  • TEFLARO (Drug) $50.99
  • ANDEXXA (Biological) $28.57
  • ELIQUIS (Drug) $24.02
  • LOKELMA (Drug) $13.85
  • IFUSE IMPLANT (Device) $12.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Trenton